Reference Line

PureOmega 1200

Evidence grade: A (100/100)

The score (0–100) is a sample-size-weighted average of each ingredient's strongest study, where study quality is ranked RCT(4) > cohort(3) > case(2) > preclinical(1) and bigger samples count more (with diminishing returns). Bands: A ≥85, B ≥70, C ≥55, D ≥40, else F. Ingredients with no study are excluded — an absent study is never scored as “bad.”

Weighted aggregate of each ingredient's strongest evidence (study quality × sample size). 2 ingredients.

View & verify badge Compare with another

Evidence at a glance

These are simple counts rolled up from the studies below. They describe how much evidence exists and how strong it is — not whether the product works. Ingredients with no indexed study are reported as insufficient, never scored as “bad.”

2Ingredients evidenced

Ingredients with at least one gradeable study.

2Studies cited

Every gradeable study record in the curated ledger behind this product. Predatory / non-indexed sources are excluded by design.

34,050Participants

Total human sample size (n) summed across the cited studies. Bigger totals mean more people were studied — a rough measure of evidence weight, not of effectiveness.

RCTStrongest study

The highest-quality study design present anywhere in this product's evidence: Randomized controlled trial. The quality ladder is RCT > cohort > case > preclinical.

Study mix:RCT: 2Cohort: 0Case: 0Preclinical: 0

Per-ingredient evidence

Studies are ordered strongest-first. Study quality is ranked RCT > cohort > case > preclinical; ties go to the larger sample size (n). An ingredient with no indexed study is marked Insufficient — never scored as “bad.”

2 studies shown

EPA/DHA Omega-3

Strongest evidence: Randomized controlled trial, n=8,179

RCT

Grade	n	Study	Finding
RCT	8,179	Cardiovascular Risk Reduction with Icosapent Ethyl (REDUCE-IT)NEJM · 2026-02-03	25% relative reduction in major adverse cardiovascular events at high dose.

Vitamin D3

Strongest evidence: Randomized controlled trial, n=25,871

RCT

Grade	n	Study	Finding
RCT	25,871	Vitamin D Supplements and Prevention of Cancer/CVD (VITAL)NEJM · 2026-02-03	No significant reduction in primary cancer or CVD endpoints overall.

Ask AI

AI can be wrong. Not medical, legal, or financial advice.

Not medical advice. Grades reflect the quality and quantity of published evidence for an ingredient — not a health claim, endorsement, or guarantee of effect. An absent study is reported as insufficient, never as proof a thing does or does not work. Talk to a clinician before changing any regimen.